Novo Nordisk to Purchase Hypertension Drug for $1.33 Billion.

Published Date: 21 Oct 2023

Novo Nordisk has reached an agreement to purchase ocedurenone from KBP Biosciences for up to $1.3 billion. The medication is used to treat uncontrolled hypertension and may also be beneficial for kidney and cardiovascular disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

2.

Study identifies new approach to protect the brain during radiation therapy

3.

While most cancer screenings won't prolong lives, there are still good reasons to continue screening.

4.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

5.

Radiation therapy for patients with breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot